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ABSTRACT
Objective: Alert fatigue limits the effectiveness of medication safety alerts, a type of computerized clinical deci-
sion support (CDS). Researchers have suggested alternative interactive designs, as well as tailoring alerts to
clinical roles. As examples, alerts may be tiered to convey risk, and certain alerts may be sent to pharmacists.
We aimed to evaluate which variants elicit less alert fatigue.
Materials and Methods: We searched for articles published between 2007 and 2017 using the PubMed, Embase,
CINAHL, and Cochrane databases. We included articles documenting peer-reviewed empirical research that de-
scribed the interactive design of a CDS system, to which clinical role it was presented, and how often prescribers
accepted the resultant advice. Next, we compared the acceptance rates of conventional CDS—presenting prescrib-
ers with interruptive modal dialogs (ie, “pop-ups”)—with alternative designs, such as role-tailored alerts.
Results: Of 1011 articles returned by the search, we included 39. We found different methods for measuring ac-
ceptance rates; these produced incomparable results. The most common type of CDS—in which modals inter-
rupted prescribers—was accepted the least often. Tiering by risk, providing shortcuts for common corrections,
requiring a reason to override, and tailoring CDS to match the roles of pharmacists and prescribers were the
most common alternatives. Only 1 alternative appeared to increase prescriber acceptance: role tailoring. Possi-
ble reasons include the importance of etiquette in delivering advice, the cognitive benefits of delegation, and
the difficulties of computing “relevance.”
Conclusions: Alert fatigue may be mitigated by redesigning the interactive behavior of CDS and tailoring CDS
to clinical roles. Further research is needed to develop alternative designs, and to standardize measurement
methods to enable meta-analyses.
Key words: alert fatigue, decision support systems, clinical, medical order entry systems, electronic prescribing, decision
support techniques
INTRODUCTION
According to the most recent U.S. government reports, 1 in every 20
deaths in the United States has been attributable to an adverse drug
event (ADE).1,2 Many ADEs result from erroneous prescriptions.3
By the most conservative estimates, 1 in every 50 prescriptions is in-
appropriate.3
Clinical decision support (CDS) is intended to reduce prescrip-
tion error by providing prescribers with automated guidance during
computerized order entry.4 Some have held high hopes for CDS, be-
lieving that it would significantly reduce prescription errors.5
The reality has proved more complex—CDS can create new
patient safety risks. For example, in some instances, “hard stops”
VC The Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association.
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have prevented patients from receiving potentially life-saving treat-
ment in time.6 The information technology infrastructures that
organizations must install to integrate CDS into the medication-
ordering process—often accompanied by changes in workflow and
communication patterns—can disrupt work during “roll-out,” as
well as in long-term use.7 These disruptions can increase instances
of ADEs, which can, in turn, increase patient mortality.7
CDS can also fail to improve patient safety due to alert fatigue.8
Alert fatigue occurs when a high number of irrelevant alerts leads
users to habitually override them. It is a term derived from alarm
fatigue, which psychologists and human factors researchers have
used when studying high false alarm rates in fields such as aviation
and nuclear power plant operation.9
Alarm fatigue was once referred to as the “cry-wolf effect” be-
cause, much like Aesop’s fable,10 it describes a situation in which
people stop responding to false alarms.9 Severe consequences can re-
sult from alarm and alert fatigue conditions. For example, a 1997
plane crash was attributed to alarm fatigue—the control tower oper-
ators had disabled a minimum safe altitude alarm due to its frequent
false alarms.11 Similarly, the patient safety goals of CDS can be com-
promised by alert fatigue.
Some researchers have focused on increasing alert sensitivity and
specificity by modifying CDS rulesets.12,13 The results have been
mixed. It is often difficult to justify disabling alerts due to safety
concerns or pressure from patient safety groups (eg, Leapfrog).14,15
Psychologists and human factors researchers have developed
strategies to reduce alarm fatigue via interaction design—the design
of the way the “dialogue” unfolds between the human user and the
computer. Some have applied these strategies in CDS, with promis-
ing results. For example, tiered alarms9 indicate the likelihood or se-
verity of an adverse event, and they seem to have been well received
in CDS.16 As another example, “patient” alarms—those that avoid
distracting airplane pilots when they are busy—may be accepted
more often than “impatient” alarms.17 Similarly, in CDS, research-
ers have implemented alerts that avoided requiring attention at a
particular time—again, with some success.18
To address whether the interactive design of CDS affects clinical
alert fatigue, in the aggregate, we conducted a systematic Preferred
Reporting Items for Systematic Reviews and Meta-Analyses19 review.
Existing systematic reviews have tended to focus on prescriber perfor-
mance and patient outcomes rather than alert acceptance.20–25 We only
found 3 published reviews that addressed interactive design.8,26,27 In
2006, van der Sijs et al8 conducted a conceptual analysis, noting that
they had identified only 9 studies that reported override rates. Subse-
quent reviews by Horsky et al26 and Miller et al27 deferred to prior
authors’ assessments of effectiveness. These assessments were based on
a variety of factors, ranging from provider usability and satisfaction to
patient morbidity and mortality. In this review, we continue this line of
inquiry by centralizing alert fatigue and specifically examining the rela-
tionship between interactive designs and prescriber acceptance rates.
Defining acceptance
We defined acceptance—our main outcome—as a change to a pre-
scription based on computerized advice. This definition excluded
“intention to monitor” and “acknowledgment”—explanations of
these concepts follow.
Some CDS alerts have allowed prescribers to select “intention to
monitor” as an override justification, and some researchers have
counted this justification-selection as evidence of “acceptance.” How-
ever, Slight et al28 found evidence of monitoring in only 36% of
instances in which the prescriber indicated an intention to monitor.
Many CDS alerts have been presented as modal dialogs (also
known as pop-ups), and some of these have provided a button that
indicates “acknowledgment,” but which takes no action. Some
researchers have considered a click of this button to count as
“acceptance”—but this, too, may rely on an incorrect assumption.
Under alert fatigue, modal dialogs become obstacles, and
“acknowledgment” buttons become the work-around.29
Additionally, in this review, we paid attention to the clinical role
of the recipient of the automated guidance, eg, a prescriber or a
pharmacist. Other authors8,30 have identified that delivering the
right guidance to the right recipient is crucial to the acceptance of
the alert.
MATERIALS AND METHODS
We conducted a systematic review according to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses19
model. We started by searching the PubMed, Embase, CINAHL,
and Cochrane literature databases. The search terms we used are
shown in Table 1. We identified articles published between 2007
and 2017. Two of the authors (T.L.R., M.I.H.) screened the search
results, extracting relevant details (interactive features, clinical roles,
acceptance rates, and methods) from included studies for analysis.
T.L.R. and M.I.H. met often to ensure consistency.
Eligibility criteria
We included peer-reviewed, English-language articles reporting em-
pirical studies about CDS for medication safety. We included articles
that documented acceptance rates, as defined in the Introduction, or
enough information to calculate an acceptance rate. When we found
more than 1 article documenting the same CDS and setting, we
retained the more thorough version.
While screening, we used the following additional criteria. First,
as our goal was to understand how prescribers acting of their own
free will responded to different interventions, we excluded “hard
stops,” which impose heavy time penalties to override, and which
therefore materially restrict the prescriber’s range of action. Readers
interested in an analysis of hard stops should refer to a 2018 system-
atic review by Powers et al.6 Second, we excluded articles that did
not describe the interactive design in enough detail to produce a de-
scription. Third, we excluded articles in which researchers made
global changes to an alerting system, but only reported acceptance
rates for those alerts intended to convey the most urgency, for cer-
tain drug categories, or for a selected subset of users exposed to the
alert; some of these authors may have chosen to report only the
most palatable results. If, on the other hand, the researchers set out
to improve acceptance of a certain type of alert, like antibiotic stew-
ardship or renal dosing, then reporting the acceptance rate for only
those alerts was considered appropriate for our analysis.
Data extraction process
For included articles, we extracted interactive features, the clinical
role that received CDS, measurement methods, acceptance rates,
and rates of override appropriateness. For articles documenting time
series trials of incremental changes to the CDS ruleset, we extracted
the last recorded result. If an article reported more than 1
intervention—for example, if the authors compared plain modal
dialogs with dialogs that provided additional context31—we
extracted results from each intervention separately. When an accep-
tance rate was not directly given, we used the equations provided by
McCoy et al32 to derive an acceptance rate.
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The same 2 authors (T.L.R., M.I.H.) split this data extraction
workload evenly and checked one another’s work. Doubts on inclu-
sion were handled by interpreting the inclusion criteria in-person to
achieve consensus.
Data analysis and synthesis of results
We coded features and measurement methods as short descriptions
(eg, “tiered modal dialog presented to the prescriber,” “counted dia-
log button-clicks”). We sorted these descriptions into categories as
commonalities emerged.
We also paid attention to the methods used to construct accep-
tance rates. In this article, we refer to the 2 main methods as in-
dialog action analysis and event analysis.
In-dialog action analysis is only applicable when the CDS inter-
vention takes the form of a dialog that features a button that the pre-
scriber can click to modify or discard their order (eg, “Discard
Warfarin Order”). Researchers count the number of times the
“acceptance” button was clicked, and divide that count by the total
number of dialogs that appeared.
Event analysis may be applied to any form of CDS, including dia-
logs. When conducting an event analysis, researchers search the pa-
tient chart for evidence that the prescriber accepted advice, in
addition to any changes that prescribers may have made by clicking
buttons inside CDS dialogs. For example, a prescriber might dismiss a
modal dialog warning against a warfarin order, and then reduce the
dose later. Or, a pharmacist might receive an alert from a CDS system,
and counsel the prescriber by phone—in which case the researchers
must check to see if the prescriber made a change to the chart.
We plotted the frequencies of measurement methods by publica-
tion year to examine their popularity over time. For those studies
that used more than 1 measurement method, we compared the
results of those measurement methods. We also plotted the frequen-
cies of interactive and role-tailoring features reported over time, to
identify trends.
Next, we used a t test to compare acceptance rates between CDS
systems by interactive design and clinical role-tailoring. In addition,
we constructed a plot to holistically examine prescribers’ acceptance
rates by feature.
RESULTS
Study selection
As shown in Figure 1, we initially identified 2699 records by query-
ing the literature databases. After removing duplicates, screening
titles, and abstracts, and examining full-texts to determine eligibil-
ity, we determined that 39 articles met our inclusion criteria.
Extracting results from these articles yielded 42 different interven-
tions, since there were 3 articles that reported 2 interventions each.
Study characteristics
The study characteristics are shown in Figure 2. Twenty-four (61%)
of the 39 included articles reported studies conducted in the United
States, and 3 (8%) reported studies from Taiwan. There were 2 stud-
ies from Switzerland, 2 from the Netherlands, and 1 from each of
the following: the United Kingdom, China, Canada, and Belgium.
Nine of the 24 (38%) studies conducted in the United States were
conducted in Harvard-affiliated institutions.
Seventeen (44%) studies were conducted in inpatient settings
only, 12 (31%) were conducted in outpatient settings only, 6 (15%)
studied both inpatient and outpatient settings, and the remaining 4
(10%) studies were conducted in the emergency department, in the
emergency department and outpatient settings, or in an unspecified
setting. Twenty-five of the 39 (64%) included articles studied aca-
demic healthcare settings, 12 (31%) studied nonacademic settings,
and the remaining 2 (5%) studied both settings.
Twenty-five of the 39 (64%) included articles documented an
electronic health record (EHR)–integrated CDS, 9 (23%) docu-
mented a standalone CDS, and 5 (13%) did not specify whether the
CDS was integrated into an EHR. Three of the 39 included articles
(8%) reported more than 1 intervention31,33,34; each intervention
was treated as a separate study.
Twenty-four (60%) of the articles solely studied physician be-
havior. Ten (26%) studied both physician and nurse practitioner
behavior and 5 (13%) did not specify the clinical roles that were
studied.
Trends in measuring acceptance
As mentioned in the Materials and Methods, we analyzed the meth-
ods that researchers used to construct acceptance rates. The number
of studies that conducted in-dialog action analyses (n ¼ 23) was ap-
proximately equal to the number of that conducted event analyses
(n ¼ 22). Eight of the studies in our analysis—all between 201232
and 2017—conducted a review of appropriateness, either of the
CDS alerts or of overriding behavior, using the method described by
Weingart et al35 in 2003.
Three articles contained measurements of prescriber acceptance
using both in-dialog action analysis and event analysis. Woods
et al36 arrived at an acceptance rate of 26% using in-dialog action
Table 1. Search query structure
Decision support. . . Advisories. . . Acceptance Rates. . . Time frame
(“allergy” OR “computer-assisted”
OR “computerised” OR
“computerized” OR “cpoe” OR
“decision support” OR “drug
interaction” OR “drug-drug inter-
action” OR “electronic pre-
scribing” OR “expert system” OR
“order check” OR “order checks”
OR “order entry” OR
“prescribing” OR “prescription”
OR “rules based”)
AND (“alert” OR “alerts” OR
“alerting” OR “alarm” OR
“message” OR “messages”
OR “prompt” OR “prompts”
OR “reminder” OR
“warning” OR “warnings”)
AND (“alert fatigue” OR “alarm
fatigue” OR “distraction” OR
“error” OR “errors” OR
“override” OR “overridden”
OR “overrode” OR “guideline
adherence” OR “non-
adherence” OR “practice
patterns” OR “practise
patterns” OR “problem” OR
“problems” OR “usability”)
AND (published between 4 Oct
2007 and 4 Oct 2017)
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analysis, and an acceptance rate of 41% using event analysis. Slight
et al37 arrived at acceptance rates of 40% and 66%, using in-dialog
action analysis and using event analysis, respectively; McCoy et al32
arrived at acceptance rates of 18% and 47%, respectively. Event
analyses generally yielded acceptance rates twice as high (194%) as
in-dialog analyses.
Records identified through 
database searching
(n =  2,699)
Additional records identified 
through other sources
(n = 0)
Records after duplicates removed
(n = 1,011)
Records screened
(n = 1,011)
Records excluded
(n = 476)
Full-text articles assessed for 
eligibility
(n = 535)
Full-text articles 
excluded, with reasons
(n = 496)
Results extracted from full-text 
articles
(n = 39)
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analysis19 flow diagram.
Geography
Other (6%)
Western Europe
(17%)
Taiwan (8%)
USA, not Harvard
(43%)
Harvard
(26%)
USA
(69%)
Setting
Inpatient only
(44%)
Outpatient only
(31%)
Inpatient and 
outpatient (15%)
ED, ED and outpatient,
or unspecified (10%)
Academic affiliation
Academic
(64%)
Non-academic
(31%)
Both (5%)
Decision support
Integrated into 
EHR (74%)
Standalone
(17%)Did not specify (9%)
Role under study
Physicians only
(61%)
Physicians and
nurse practitioners
(26%)
Did not specify (13%)
Figure 2. Study characteristics. ED: emergency department; EHR: electronic health record.
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Trends in CDS interventions
Features present in 4 or more included studies are plotted cumula-
tively, over time, in Figure 3. Three of the most common interactive
features—tiering alerts, providing shortcuts for common corrective
actions, and requiring a reason to override—are described and illus-
trated in Table 2.
The most commonly reported type of CDS—which comprised
83% of results—interrupted prescribers with modal dialogs. The
most common variants were tiered to convey levels of risk, provided
shortcuts for common corrections, or required a reason to override.
We also found advisories that were not automatically issued us-
ing computerized systems. These included fax or mail alerts, and
Cumulative Features by Year
N
um
be
r o
f P
ap
er
s
0
9
18
27
36
2007 2009 2011 2013 2015 2017
Modals Interrupted Prescribers Alerts Tiered
No Modals Interrupted Prescribers Modals Required Override Reason
Pharmacists Received CDS Modals Provided Action Shortcuts
Figure 3. Feature prevalence over time. “Pharmacists Received CDS” is a subcategory of “No Modals Interrupted Prescribers.” All others are subcategories of
“Modals Interrupted Prescribers.” CDS: clinical decision support.
Table 2. Common interactive features
Name and description Sample design
Tiered
Alerts present an indication of the risks associated with an override. In
some cases, higher-priority alerts are modal dialogs, while lower-priority
alerts are modeless.
Danger
x
This is an example 
of a high-tier alert. 
Alert contents go 
here.
CDS
AcceptCancel
Caution
x
This is an example 
of a low-tier alert. 
Alert contents go 
here.
CDS
AcceptCancel
Warning
x
This is an example 
of a mid-tier alert. 
Alert contents go 
here.
CDS
AcceptCancel
Action shortcuts
Modal dialogs provide the ability to perform common corrections. For ex-
ample, one might wish to reduce the dose, or substitute another medica-
tion, rather than discard an order altogether.
x
50 mg is a high 
dose. Would you like 
to reduce to 25 mg? 
CDS
Reduce dose
Keep order as-is
Discard order
Override reason required
Modal dialogs mandated that the prescriber provide a justification prior
to dismissal. Justifications may be solicited with a pick-list, a free-text
field, or both.
x
You must provide a 
reason to override 
the advice of this 
computer program.
CDS
AcceptCancel
Select Reason
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interactive designs in which a user manually retrieved a list of
alerts38 or manually triggered a battery of modal dialogs.33 Only 1
article documented a design that allowed the user to dismiss a
modal, and then retrieve it later for reference, rather than memoriz-
ing the contents of the alert.38 A list of all designs for presenting
CDS is available in the Supplementary Appendix.
CDS acceptance by feature
For the analysis of feature acceptance, we included the 22 studies
that used event analysis. Of those studies, 15 (68%) were based on
CDS systems that interrupted prescribers with modal dialogs.
Among the 7 alternatives, 4 (18%) presented alerts pertaining to
areas such as antimicrobial stewardship or renal dosing to pharma-
cists,39–42 2 (9%) delivered fax or mail alerts to prescribers,43,44 and
1 (4.5%) depended on the prescriber to manually trigger a review
process.38
We compared those interventions that interrupted prescribers
with modal dialogs with all other interventions. The group of alter-
native interventions included any alerts that were sent to the phar-
macist instead of the prescriber, as well as any alerts that were sent
to the prescriber but were not modal dialogs. Using a t test, we
found that prescriber-interrupting modals were accepted signifi-
cantly less often, as predicted (38.67% v. 61.57%; P¼ .026). The
acceptance rate distributions are shown in Figure 4.
Our plot of acceptance rates by CDS feature is shown in Figure 5.
In that figure, CDSs with multiple features appear on multiple lines.
For example, a CDS that interrupted prescribers with tiered modal
dialogs will appear twice in the figure, once on the “Modals Inter-
rupted Prescribers” line, and once on the “Alerts Tiered to Convey
Risk” line.
Visual inspection suggested that prescribers accepted advice
from CDS-guided pharmacists more frequently and with less vari-
ability than they accepted advice when interrupted by modal
dialogs.
DISCUSSION
In this systematic review, we found that interrupting prescribers
with modal dialogs have become the least accepted—yet the most
prevalent—design. In this section, we analyze possible reasons to ac-
count for this observation. Afterward, we discuss some methodolog-
ical dilemmas faced in CDS research. Some of these have been a
matter of methodological inconsistency—and they presented a prac-
tical barrier to meta-analysis. Finally, we conclude this section with
our recommendations to improve the quality of CDS design and re-
search.
Reasons why prescriber-interruptive modals seem to
elicit alert fatigue
When we compared prescriber-interruptive modal dialogs with
alternatives, we found evidence favoring the alternatives—in partic-
ular, those that tailored CDS to the roles of pharmacists and physi-
cians. We believe there are 3 explanations for this finding. The first
concerns etiquette—“proper” etiquette often makes advice easier to
receive. The second concerns the division of expert labor between
prescribers and pharmacists. The third concerns relevance, which
comes naturally to humans, but which remains difficult to compute.
Etiquette. In the Introduction, we mentioned that psychologists
and human factors researchers tend to endorse presenting guidance
“politely”—even in emergencies.17 Prescribers might have accepted
pharmacists’ advice so readily because those pharmacists produced
behavioral patterns culturally recognized as “polite.” In some cases,
it is appropriate to carefully design and program computers to pro-
duce similar “behavior” to solicit the user’s reciprocity.45 Some of
the modal dialogs that we saw, which featured large, capitalized red
text, and which required several clicks and keystrokes to dismiss,
might have been seen as patronizing, rather than polite. In our re-
view, attempts to imitate “politeness” in CDS were rare to find.
Division of expert labor. It has been common practice for pre-
scribers to consult pharmacists about the appropriateness of particu-
lar medications for patient cases.46 Presenting certain medication-
related CDS to the pharmacist—such as those concerning antibiotic
targeting and renal dosing—therefore may support (rather than dis-
rupt) an established clinical practice. This division of expert labor
might have a hidden advantage: Sheltering prescribers from most of
the details of pharmacy review might allow prescribers to focus
more of their attention on the key details of clinical cases, so that
they may think more clearly.47 We understand this may not be feasi-
ble in certain cases until regulatory barriers are changed.
Relevance. Prescribers may have found pharmacist-mediated
CDS alerts highly acceptable because pharmacists filtered out irrele-
vant advice. Whether computers might, someday, handle relevance
and context as capably as humans has been a matter of debate.48–50
Prescriber Acceptance by Feature
Modals Interrupted Prescribers
Pharmacists, Not Prescribers, Received CDS
Alerts Tiered to Convey Risk
Modals Provided Action Shortcuts
Modals Required a Reason to Override
Alerts Mailed or Faxed
Users Could Configure Threshold
Modals Provided Additional Context
Review Triggered by Prescribers
Only Specialist Could Override High-Tier Alerts
Acceptance Rate (%)
0     20      40       60      80     100
Figure 5. Prescribers’ acceptance rates for clinical decision support (CDS) ad-
vice, by feature, measured using event analysis. CDSs with multiple features
appear on multiple lines.
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Figure 4. Boxplot comparing how often prescribers accepted advice directly
from interruptive modal dialogs vs alternatives.
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Indeed, CDS does not seem to perform at the same level of precision
and relevance as the humans they advise.51
The prevalence of prescriber-interruptive modal dialogs in the
literature might be due to overly narrow definitions of “decision
support” by certain patient advocacy groups15 or it may be due to
actual prevalence in clinics. Additionally, EHR homogenization52
may have determined which types of decision support have been
convenient for clinical institutions to implement, and which have
been expensive, at scale.
CDS homogeneity presented 1 of several barriers to meta-
analysis. The other barriers were primarily due to methodological
inconsistencies in the literature. Next, we discuss methodological
issues.
Mediation analysis may address methodological
dilemmas
As mentioned in the Results, we found that researchers had been us-
ing 2 main ways to measure how often a prescriber accepted
computer-generated advice: in-dialog action analysis and event anal-
ysis. Some studies explicitly conducted comparative analyses of the
validity of the 2 methods.32,36,37
As previously mentioned, when using in-dialog action analysis,
the researchers dichotomize the actions taken inside a modal dialog:
The prescriber either accepts the alert (eg, by clicking “Discard
Order”) or overrides it (eg, by clicking “Proceed Anyway”). We
note 3 problems with this method’s validity. First, those clicks pro-
vide a rather partial story of the order—for example, they do not ac-
count for possible corrections that the prescriber may take after
responding to the alert. This is related to the second problem: Apply-
ing in-dialog action analysis to modals that feature action shortcuts
may artificially inflate acceptance rates with respect to other modal
dialogs, because more actions that would otherwise take place out-
side the dialog would instead take place inside the dialog. Third, in-
dialog action analysis cannot be used with CDS interventions that
do not offer decision-buttons to prescribers—these interventions
must be studied with event analysis.
When using event analysis, the researcher additionally searches
for corrective actions that the prescriber made after dismissing any
alert, including a modal dialog. For example, the prescriber may
change a dose, or switch to a narrow-spectrum antibiotic, after dis-
missing a modal dialog. These adjustments are taken as evidence of
acceptance. This main problem with this method’s validity is that
there is no way to know whether the prescriber would have taken
the same action if the intervention had not been delivered.
One might expect that in-dialog action analysis errs on the side of
specificity (it systematically fails to recognize corrective actions), while
event analysis errs on the side of sensitivity (it may misattribute some
corrections to interventions). The evidence we gathered from 3 studies
that compared these 2 methods32,36,37 suggest that this intuition is
correct. These methods are biased, in a traditional sense: they produce
results that predictably depart from the results that one would expect
from the most accurate instrument imaginable.
Despite their limitations, we believe these methods to be valu-
able, as they seem to be the most cost-effective ways to capture data
for CDS acceptance. However, we must caution that these methods
produce results that are noncomparable. We suggest using event
analysis, to enable rigorous comparisons between modal and mode-
less forms of CDS.
Appropriateness panel reviews,32,35 were rare to see. We imagine
these reviews to be particularly costly. Indeed, half of the included
articles that reported an appropriateness review were from well-
resourced academic institutions.
In fact, the scarcity of information that was useful in our re-
view was surprising given the quantity of available CDS litera-
ture. Nearly 9 in 10 of the articles we excluded did not report
prescriber acceptance, an important mediating variable between
the technological intervention and patient outcomes that seems
to have been assumed. Earlier, we described a homogeneity of
CDS interventions in the reported literature—specifically,
prescriber-interruptive modal dialogs comprised 5 in 6 included
results. This also constrained the analyses that could be con-
ducted with adequate statistical power. Finally, a roughly 50-50
split between 2 incomparable measurement methods precluded
meta-analysis.
This review revealed several issues in the literature. Future
work is needed to develop standardized, low-cost, informative
measures for determining acceptance for CDS, and for relating
CDS acceptance to patient outcomes. Next, we present some
feasible recommendations for improving the quality of the CDS lit-
erature.
Recommendations for future work
Given the preceding discussion, we propose the following 3 recom-
mendations for future CDS research:
First, we recommend that researchers consider alternatives to
prescriber-interruptive modal dialogs, since there is evidence that
the latter suffers from relatively lower acceptance. Role-based tailor-
ing appeared to improve acceptance rates, and further work is
needed in this area. Ideally, those who will receive the alerts should
be involved in role-tailoring decisions. Alternatives to modal dialogs
should also be explored.
Second, recommend measuring acceptance rates using event
analysis, rather than in-dialog action analysis. Because event analy-
sis is more widely applicable, using it will enable meta-analyses that
accommodate varied CDS interventions.
Last, we recommend reporting both acceptance rates and patient
outcomes. Much of the literature that we saw in our review reported
one or the other; few reported both. This has made it difficult to an-
alyze patient outcomes as a function of CDS design and role-
tailoring, mediated53 by acceptance.
CONCLUSION
Alert fatigue remains a persistent challenge in CDS. Among
prescriber-interruptive modal dialogs, acceptance rates have been
highly variable. In our analysis, prescribers accepted alternative
interventions more often—especially those which tailored CDS to
the areas of expertise associated with clinical roles. Although there
are plausible reasons why some alternative CDS interventions would
improve acceptance, contemporary literature has not supported de-
tailed analyses. We recommend that future studies pay more atten-
tion to alternative designs, measure acceptance using event analysis,
and report patient outcomes as well as acceptance rates.
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